CUKTECH Makes Its Debut in Singapore, Introducing A Range of Innovative Products
SINGAPORE, Jan. 23, 2024 /PRNewswire/ -- CUKTECH, an integral member of the Xiaomi ecosystem, proudly announces its entry into the Singaporean market, marking a pivotal moment in its global outreach. The company is set to unveil a variety of new...
Endowus launches CashUp Portfolios offering institutional-grade, flexible short-term cash management solution for Hong Kong investors
New investment offering enables investors to manage their short-term cash with access to institutional share class money market funds at lower fees, with projected net yields of up to 5.5%* per annum HONG KONG, Jan. 23, 2024 /PRNewswire/ -- Endowus,...
GMCC & Welling Ignite AHR Expo 2024 with One-Stop Full-Scenario HVAC and Refrigeration Solutions
CHICAGO, Jan. 22, 2024 /PRNewswire/ -- GMCC & Welling showcased their comprehensive portfolio and solutions in AHR Expo 2024 in Chicago, United States that with a full scenario coverage of residential air conditioners, commercial air...
Sevilla FC Transforms the Player Recruitment Process with the Power of IBM watsonx Generative AI
Sevilla FC introduce Scout Advisor, an innovative tool built on IBM's watsonx platform, to enhance player recruitment process. "Scout Advisor" is designed to unlock the full potential of Sevilla FC extensive players database to create new...
Leading with Lifestyle: How Timo Digital Bank is Changing the Financial Game in Vietnam?
HO CHI MINH CITY, Vietnam, Jan. 23, 2024 /PRNewswire/ -- As a pioneer in digital banking services, Timo has long been on a mission of continuously setting the benchmark. Starting from free bank transfers and ATM withdrawals 8 years ago, Timo since...
Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis - Primary efficacy endpoints: NASH resolution without worsening of...
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)
YONGIN, South Korea, Jan. 23, 2024 /PRNewswire/ -- GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its intracerebroventricular (ICV) Enzyme Replacement Therapy (ERT)...
LPS Unveils New Brand Identity, Fully Embracing Lenovo's AI for All Transformation Journey in Asia Pacific
Rebranding supports Lenovo's vision – 'AI for ALL' – by collaboratively enhancing AI-powered services and solutions to propel smarter city development HONG KONG, Jan. 23, 2024 /PRNewswire/ -- Lenovo PCCW Solutions (LPS) today announced a leap in...